Octave Biosciences

Octave Bioscience is a private, commercial-stage precision care company focused on neurodegenerative disease, with its initial and primary emphasis on multiple sclerosis. The company markets the Octave MSDA Test, a blood-based, multi-analyte protein assay designed to measure MS disease activity and support treatment monitoring and care decisions. Beyond the assay itself, Octave positions its offering as an integrated precision care platform that combines biomarker, imaging, clinical, and analytics capabilities. The company is expanding its neurology pipeline beyond MS, including work in Parkinson's disease and broader neurodegenerative applications. Octave partners across the care ecosystem, including diagnostics distribution and access relationships such as Quest Diagnostics, to broaden clinical adoption.